| Ivermectin reduces alcohol intake and preference in mice MM Yardley, L Wyatt, S Khoja, L Asatryan, MJ Ramaker, DA Finn, ... Neuropharmacology 63 (2), 190-201, 2012 | 73 | 2012 |
| P2X4 receptor reporter mice: sparse brain expression and feeding-related presynaptic facilitation in the arcuate nucleus J Xu, AM Bernstein, A Wong, XH Lu, S Khoja, XW Yang, DL Davies, ... Journal of Neuroscience 36 (34), 8902-8920, 2016 | 61 | 2016 |
| Sociocommunicative and sensorimotor impairments in male P2X4-deficient mice LR Wyatt, SC Godar, S Khoja, MW Jakowec, RL Alkana, M Bortolato, ... Neuropsychopharmacology 38 (10), 1993-2002, 2013 | 61 | 2013 |
| Contribution of P2X4 receptors to ethanol intake in male C57BL/6 mice LR Wyatt, DA Finn, S Khoja, MM Yardley, L Asatryan, RL Alkana, ... Neurochemical research 39, 1127-1139, 2014 | 56 | 2014 |
| Pharmacological insights into the role of P2X4 receptors in behavioural regulation: lessons from ivermectin M Bortolato, MM Yardley, S Khoja, SC Godar, L Asatryan, DA Finn, ... International Journal of Neuropsychopharmacology 16 (5), 1059-1070, 2013 | 55 | 2013 |
| Role of purinergic P2X4 receptors in regulating striatal dopamine homeostasis and dependent behaviors S Khoja, V Shah, D Garcia, L Asatryan, MW Jakowec, DL Davies Journal of neurochemistry 139 (1), 134-148, 2016 | 52 | 2016 |
| Avermectins differentially affect ethanol intake and receptor function: implications for developing new therapeutics for alcohol use disorders L Asatryan, MM Yardley, S Khoja, JR Trudell, N Hyunh, SG Louie, ... International Journal of Neuropsychopharmacology 17 (6), 907-916, 2014 | 35 | 2014 |
| Dopamine receptor blockade attenuates purinergic P2X4 receptor-mediated prepulse inhibition deficits and underlying molecular mechanisms S Khoja, L Asatryan, MW Jakowec, DL Davies Frontiers in Cellular Neuroscience 13, 331, 2019 | 23 | 2019 |
| Preclinical evaluation of avermectins as novel therapeutic agents for alcohol use disorders S Khoja, N Huynh, AMP Warnecke, L Asatryan, MW Jakowec, DL Davies Psychopharmacology 235, 1697-1709, 2018 | 23 | 2018 |
| Reduced expression of purinergic P2X4 receptors increases voluntary ethanol intake in C57BL/6J mice S Khoja, N Huynh, L Asatryan, MW Jakowec, DL Davies Alcohol 68, 63-70, 2018 | 20 | 2018 |
| Chronic ethanol exposure combined with high fat diet up-regulates P2X7 receptors that parallels neuroinflammation and neuronal loss in C57BL/6J mice L Asatryan, S Khoja, KE Rodgers, RL Alkana, H Tsukamoto, DL Davies Journal of neuroimmunology 285, 169-179, 2015 | 18 | 2015 |
| Advances in neurexin studies and the emerging role of neurexin-2 in autism spectrum disorder S Khoja, MT Haile, LY Chen Frontiers in molecular neuroscience 16, 1125087, 2023 | 10 | 2023 |
| Conditional deletion of Neurexin-2 alters neuronal network activity in hippocampal circuitries and leads to spontaneous seizures MT Haile, S Khoja, G de Carvalho, RF Hunt, LY Chen Translational psychiatry 13 (1), 97, 2023 | 4 | 2023 |
| A novel pharmacotherapy approach using P-glycoprotein (PGP/ABCB1) efflux inhibitor combined with ivermectin to reduce alcohol drinking and preference in mice J Silva, S Khoja, L Asatryan, E Pacifici, DL Davies Alcohol 86, 1-8, 2020 | 4 | 2020 |
| Early life adversity impaired dorsal striatal synaptic transmission and behavioral adaptability to appropriate action selection in a sex-dependent manner G de Carvalho, S Khoja, MT Haile, LY Chen Frontiers in Synaptic Neuroscience 15, 1128640, 2023 | 2 | 2023 |
| The avermectin family as potential therapeutic compounds for alcohol use disorder: Implications for using P2X4 receptor as a drug-screening platform N Huynh, S Khoja, L Asatryan, MW Jakowec, DL Davies Neuroscience of Alcohol, 661-670, 2019 | 2 | 2019 |
| Conditional deletion of neurexin-2 impaired behavioral flexibility to alterations in action–outcome contingency S Khoja, LY Chen Scientific Reports 14 (1), 10187, 2024 | | 2024 |
| A NOVEL PHARMACOTHERAPY APPROACH USING P-GLYCOPROTEIN (PGP/ABCB1) EFFLUX INHIBITORS COMBINED WITH IVERMECTIN TO REDUCE ALCOHOL DRINKING, PREFERENCE IN MICE DL Davies, J Silva, C Xue, J Zhang, J Liang, S Khoja, L Asatryan, ... ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH 44, 21-21, 2020 | | 2020 |
| Elucidation of the purinergic P2X4‐dopamine receptor interaction in regulation of sensorimotor gating and underlying signaling molecules S Khoja, L Asatryan, MW Jakowec, DL Davies The FASEB Journal 34 (S1), 1-1, 2020 | | 2020 |
| DEVELOPMENT OF AVERMECTINS AS AN ADJUNCTIVE THERAPY FOR PARKINSON DISEASE S Khoja, AMP Warnecke, A Asatryan, MW Jakowec, DL Davies PURINERGIC SIGNALLING 14, S93-S93, 2018 | | 2018 |
